Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CareDx, Inc.CDNA · Entity 4344 | Director | May 14, 2026 | May 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CareDx, Inc.
Report date May 14, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 38,665 |
Ending reported balance
After 2026-05-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-14 · Sale · Disposed 4,086 · Balance 45,149 F1: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.96 to $21.03 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-05-15 · Sale · Disposed 6,484 · Balance 38,665 F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.73 to $20.105 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.96 to $21.03 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.73 to $20.105 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2026 Filed May 18, 2026 20:05 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 6,484 | $19.89 | $128,977.78 |
DisclosureSEC source: 0001251737-26-000001 · form4-05182026_040501.xml · nonDerivative · entry 2 TORRES ARTHUR A · CIK 0001251737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,665 F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.73 to $20.105 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:05 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 4,086 | $20.97 | $85,697.72 |
DisclosureSEC source: 0001251737-26-000001 · form4-05182026_040501.xml · nonDerivative · entry 1 TORRES ARTHUR A · CIK 0001251737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,149 F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.96 to $21.03 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:30 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 12,103 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-087409 · ownership.xml · nonDerivative · entry 1 TORRES ARTHUR A · CIK 0001251737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,235 F1 · shares: The reported securities are represented by restricted stock units which shall vest in one installment on the earlier of (i) June 13, 2026 or (ii) the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 20:45 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantStock Option (right to buy) · Derivative | 16,048 | $0.00 Strike: $9.35 | $0.00 |
DisclosureSEC source: 0000950170-24-074960 · ownership.xml · derivative · entry 2 TORRES ARTHUR A · CIK 0001251737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,048 Underlying: Common Stock · 16,048 shares Expires 2034-06-14 F2 · derivative.exercise_date: 1/12th of the shares subject to this option shall vest on July 14, 2024, and 1/12th of the shares subject to the option shall vest monthly thereafter through June 14, 2025. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 20:45 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 10,570 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-074960 · ownership.xml · nonDerivative · entry 1 TORRES ARTHUR A · CIK 0001251737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,132 F1 · shares: The reported securities are represented by restricted stock units which shall vest in one installment on June 14, 2025. Read SEC document |
| June 14, 2024 Filed Jun 20, 2024 20:46 UTC Amendment | CareDx, Inc. CDNA · Entity 4344 | GrantStock Option (right to buy) · Derivative | 16,048 | $0.00 Strike: $14.19 | $0.00 |
DisclosureSEC source: 0000950170-24-075662 · ownership.xml · derivative · entry 1 TORRES ARTHUR A · CIK 0001251737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,048 Underlying: Common Stock · 16,048 shares Expires 2034-06-14 F1 · derivative.exercise_price: This amendment is being filed to correct the exercise price of the derivative security of the Stock Option (right to buy) reported on the original Form 4. F2 · derivative.exercise_date: 1/12th of the shares subject to this option shall vest on July 14, 2024, and 1/12th of the shares subject to the option shall vest monthly thereafter through June 14, 2025. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 22:49 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock · Derivative | 29,136 | $0.00 Strike: $7.96 | $0.00 |
DisclosureSEC source: 0001217234-23-000121 · wf-form4_168738776410677.xml · derivative · entry 2 TORRES ARTHUR A · CIK 0001251737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,136 Underlying: Common Stock · 29,136 shares Expires 2033-06-16 F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 16, 2023 and the shares subject to the option shall vest monthly thereafter through June 16, 2024. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 22:49 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 18,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001217234-23-000121 · wf-form4_168738776410677.xml · nonDerivative · entry 1 TORRES ARTHUR A · CIK 0001251737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,562 F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 16, 2024. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 20:58 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock · Derivative | 7,606 | $0.00 Strike: $20.56 | $0.00 |
DisclosureSEC source: 0001217234-22-000111 · wf-form4_165584510083140.xml · derivative · entry 2 TORRES ARTHUR A · CIK 0001251737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,606 Underlying: Common Stock · 7,606 shares Expires 2032-06-16 F2 · derivative.exercise_date: 1/12th of the shares subject to the option shall vest on July 16, 2022 and the shares subject to the option shall vest monthly thereafter through June 16, 2023. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 20:58 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 4,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001217234-22-000111 · wf-form4_165584510083140.xml · nonDerivative · entry 1 TORRES ARTHUR A · CIK 0001251737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,718 F1 · shares: The reported securities are represented by restricted stock units which shall vest on June 16, 2023. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:47 UTC | CareDx, Inc. CDNA · Entity 4344 | PurchaseCommon Stock | 600 | $47.62 | $28,572.00 |
DisclosureSEC source: 0001217234-21-000239 · wf-form4_163649801400306.xml · nonDerivative · entry 1 TORRES ARTHUR A · CIK 0001251737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,855 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 21:59 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantStock Option (right to buy) · Derivative | 2,255 | $0.00 Strike: $66.51 | $0.00 |
DisclosureSEC source: 0001217234-21-000215 · wf-form4_163182954884878.xml · derivative · entry 2 TORRES ARTHUR A · CIK 0001251737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,255 Underlying: Common Stock · 2,255 shares Expires 2031-09-15 F2 · derivative.exercise_date: 1/36th of the shares subject to the option shall vest on October 15, 2021 and 1/36th of the shares subject to the option shall vest monthly thereafter. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 21:59 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 2,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001217234-21-000215 · wf-form4_163182954884878.xml · nonDerivative · entry 1 TORRES ARTHUR A · CIK 0001251737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,255 F1 · shares: The reported securities are represented by restricted stock units 1/3rd of which shall vest on September 15, 2022 and 1/3rd of which shall vest on each anniversary thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.